IL2 and metabolic syndrome: The release of IL-2, IL-4, IL-6, IL-10, and TNF-α cytokines by the Th1 cells involved in the pathogenesis of LP has been implicated in the development of metabolic syndrome too; a positive correlation between this condition and LP highlights the issue of potential metabolic connections in LP/OLP patients [175].